Intolerance to caffeine may increase susceptibility to rheumatoid arthritis: comment on the article by Mikuls et al.

H. Mcgrath

DOI: https://doi.org/10.1002/ART.10490

2002-11-01

Arthritis & Rheumatism

Abstract:

What problem does this paper attempt to address?

The Role of Dietary Fiber in Rheumatoid Arthritis Patients: A Feasibility Study

Julian Häger,Holger Bang,Melanie Hagen,Michael Frech,Pascal Träger,Maria V. Sokolova,Ulrike Steffen,Koray Tascilar,Kerstin Sarter,Georg Schett,Jürgen Rech,Mario M. Zaiss

DOI: https://doi.org/10.3390/nu11102392

IF: 5.9

2019-10-07

Nutrients

Abstract:Short-chain fatty acids are microbial metabolites that have been shown to be key regulators of the gut–joint axis in animal models. In humans, microbial dysbiosis was observed in rheumatoid arthritis (RA) patients as well as in those at-risk to develop RA, and is thought to be an environmental trigger for the development of clinical disease. At the same time, diet has a proven impact on maintaining intestinal microbial homeostasis. Given this association, we performed a feasibility study in RA patients using high-fiber dietary supplementation with the objective to restore microbial homeostasis and promote the secretion of beneficial immunomodulatory microbial metabolites. RA patients (n = 36) under routine care received daily high-fiber bars or cereals for 28 days. Clinical assessments and laboratory analysis of immune parameters in blood and stool samples from RA patients were done before and after the high-fiber dietary supplementation. We observed an increase in circulating regulatory T cell numbers, favorable Th1/Th17 ratios, as well as decreased markers of bone erosion in RA patients after 28 days of dietary intervention. Furthermore, patient-related outcomes of RA improved. Based on these results, we conclude that controlled clinical studies of high-fiber dietary interventions could be a viable approach to supplement or complement current pharmacological treatment strategies.

nutrition & dietetics
Long-term Consumption of Caffeine-Free High Sucrose Cola Beverages Aggravates the Pathogenesis of EAE in Mice

Guangchao Cao,Qian Wang,Wanjun Huang,Jiyu Tong,Dewei Ye,Yan He,Zonghua Liu,Xin Tang,Hao Cheng,Qiong Wen,Dehai Li,Hau-Tak Chau,Yiming Wen,Hui Zhong,Ziyu Meng,Hui Liu,Zhenzhou Wu,Liqing Zhao,Richard A Flavell,Hongwei Zhou,Aimin Xu,Hengwen Yang,Zhinan Yin

DOI: https://doi.org/10.1038/celldisc.2017.20

IF: 38.079

2017-01-01

Cell Discovery

Abstract:Epidemiological data provide strong evidence of dramatically increasing incidences of many autoimmune diseases in the past few decades, mainly in western and westernized countries. Recent studies clearly revealed that 'Western diet' increases the risk of autoimmune diseases at least partially via disrupting intestinal tight junctions and altering the construction and metabolites of microbiota. However, the role of high sucrose cola beverages (HSCBs), which are one of the main sources of added sugar in the western diet, is barely known. Recently, a population study showed that regular consumption of sugar-sweetened beverages is associated with increased risk of seropositive rheumatoid arthritis in women, which provokes interest in the genuine effects of these beverages on the pathogenesis of autoimmune diseases and the underlying mechanisms. Here we showed that long-term consumption of caffeine-free HSCBs aggravated the pathogenesis of experimental autoimmune encephalomyelitis in mice in a microbiota-dependent manner. Further investigation revealed that HSCBs altered community structure of microbiota and increased Th17 cells. High sucrose consumption had similar detrimental effects while caffeine contamination limited the infiltrated pathogenic immune cells and counteracted these effects. These results uncovered a deleterious role of decaffeinated HSCBs in aggravating the pathogenesis of experimental autoimmune encephalomyelitis in mice.
Influence of C677T Polymorphism of 5,10-Methylenetetrahydrofolate Reductase on Methotrexate Toxicity

YAN Xu-yan,XU Dong-hang

DOI: https://doi.org/10.3321/j.issn:1001-2494.2007.01.020

2007-01-01

Abstract:OBJECTIVE To investigate the relationship between the mutation of 5,10-methylenetetrahydro-folate reductase(MTHFR) gene 677 C→T and the adverse drug reaction of methotrexate(MTX) in patients with rheumatoid arthritis((RA).)METHODS A total of 210 patients with RA were divided into MTX group,MTX+sulphasalazine(SASP) group,MTX+ Leflunomide(LEF) group and LEF+SASP group.100 healthy subjects were chosed as control group. PCR-restrictive fragment length polymorphism(RFLP) analysis was conducted to test mutation.The clinical measurements,laboratory measurements,the Disease Activity Score(DAS) were evaluated during 48 weeks.And the cases of adverse drug reaction(ADR) were also collected.RESULTS No difference was tained the three with genotypes of MTHFR.The frequencies of adverse drug reaction of patients with heterozygous(CT),and homozygous(TT) mutation in MTX,MTX+SASP,MTX+LEF was more than that without mutation(CC).Patients with heterozygous or homozygous mutation in the MTHFR gene induced a significantly higher plasma homocysteine at week 48,compared with those without mutation.But there was no statistical significance observed amonc CT,TT and CC when in LEF+SASP group.CONCLUSION MTHFR gene C677T mutation is probably one of the genetic risk factors for adverse drug reaction of MTX.
Adenosine receptor A2a blockade by caffeine increases IFN–gamma production in Th1 cells from patients with rheumatoid arthritis

L Gloyer,V Golumba-Nagy,A Meyer,S Yan,J Schiller,M Breuninger,D Jochimsen,DM Kofler

DOI: https://doi.org/10.1080/03009742.2021.1995956

2022-01-13

Scandinavian Journal of Rheumatology

Abstract:OBJECTIVE: Studies indicate that caffeine uptake may be a risk factor for rheumatoid arthritis (RA), but a definitive link between caffeine consumption and RA has not been established. This study aimed to investigate the interplay between caffeine, adenosine receptor A2a, and interferon-γ (IFN-γ) production in CD4+ T cells from RA patients.METHOD: Peripheral blood mononuclear cells were obtained from the peripheral blood of healthy individuals and patients with RA. CD4+ T cells were isolated using the magnetic activated cell sorting technique and cultured in vitro with caffeine or mock control. In addition, adenosine was used as a competitive inhibitor of caffeine. After 48 h, expression of IFN-γ and interleukin-17 (IL-17) was analysed by flow cytometry. Ex vivo expression levels of adenosine receptor A2a were also assessed.RESULTS: Caffeine promoted IFN-γ production in Th1 cells in vitro. Significantly higher concentrations of caffeine were required to increase IFN-γ levels in Th1 cells from healthy individuals compared to Th1 cells from patients with RA. Moreover, ex vivo levels of adenosine receptor A2a expression on CD4+ T cells were significantly higher in RA than in healthy individuals. Caffeine-driven IFN-γ production was completely reversed by adenosine, a competitive agonist of adenosine receptor A2a. In contrast to IFN-γ, production of IL-17 was not affected by caffeine.CONCLUSION: Caffeine promotes IFN-γ production in Th1 cells from RA patients in vitro by competitive inhibition of adenosine receptor A2a. Excessive coffee consumption could contribute to T-cell activation and inflammation in RA.

rheumatology
Effect of caffeine intake on self-reported and genetic prediction of osteoarthritis: an epidemiological study and Mendelian randomization analysis

Zhongkai Ji,Yucheng Shen,Dong Chen,Zhidong Liu,Jiuming Dai,Bin Dai,Wei Deng

DOI: https://doi.org/10.3389/fnut.2024.1405161

2024-07-17

Abstract:Background: Osteoarthritis (OA) holds the distinction of being the most widespread musculoskeletal disorder. Any disruptions in the integrity of the articular cartilage can result in joint malfunction, discomfort, and impaired physical functioning. Increasing evidence indicates the negative impacts of caffeine intake on hyaline cartilage. The primary objective of this study was to delve deeper into understanding the potential link between the consumption of caffeine and the risk of developing OA. Methods: In this study, we constructed logistic regression models to evaluate the correlation between caffeine consumption and the risk of osteoarthritis using data from the National Health and Nutrition Examination Survey. Following that, we utilized genome-wide association studies to conduct a Mendelian randomization (MR) analysis investigating the association between coffee consumption and the likelihood of developing knee OA. We employed various statistical methods, including inverse variance weighting (IVW), weighted median, weighted mode, simple mode, and MR-Egger regression, to ensure comprehensive analysis and robust conclusions. To evaluate heterogeneity and the potential impact of pleiotropy, we conducted several statistical tests, including Cochran's Q test, MR-Egger intercept test, MR Pleiotropy RESidual Sum and Outlier test (MR-PRESSO), and MR Steiger test. Results: The weighted multivariate logistic regression analysis showed that the relationship between high caffeine intake (95-206 and ≥206 mg/day) and OA prevalence remained significantly high even after adjusting for covariates using the lowest caffeine intake (< 11 mg/day) as reference: Model 1-OR (95% Cl) = 1.365 (1.18-1.58) and 1.59 (1.38-1.83); Model 2-OR (95% Cl) = 1.21 (1.04-1.42) and 1.44 (1.23-1.68); and Model 3-OR (95% Cl) = 1.19 (1.01-1.40) and 1.30 (1.10-1.52), respectively (p < 0.05). The findings from the fixed effects inverse variance weighted (IVW) analysis revealed a statistically significant link between coffee intake and the likelihood of developing knee osteoarthritis: OR = 1.94; 95% confidence interval (Cl) =1.471-2.517; (p < 0.001). Consistent findings were obtained across various other methods, including MR-Egger regression, weighted median, weighted mode, and simple mode analyses. Conclusion: Our study showed a positive correlation between OA prevalence and high caffeine intake (≥95 mg/day).
Influence of MHCIITA rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis

M Garcia-Bermudez,C González-Juanatey,R Lopez-Mejias,L Rodriguez-Rodriguez,S Pérez-Esteban,S Castañeda,E Urcelay,J A Miranda-Filloy,C Gómez-Vaquero,B Fernández-Gutierrez,A Balsa,I González-Alvaro,R Blanco,J Llorca,J Martín,M A Gonzalez-Gay

Abstract:Objectives: MHCIITA is a major regulator of MHC expression that has been reported to be involved in the susceptibility to rheumatoid arthritis (RA) and myocardial infarction. In this study we investigated the potential association of two MHCIITA gene polymorphisms with cardiovascular (CV) risk in patients with RA. Methods: 1302 patients fulfilling the 1987 ACR classification criteria for RA were genotyped for the MHCIITA rs3087456 and rs4774 gene polymorphisms to determine the influence of MHCIITA variants in the development of CV events. The potential influence of these polymorphisms in the development of subclinical atherosclerosis was also analysed in a subgroup of patients with no history of CV events by the assessment of two surrogate markers of atherosclerosis; brachial and carotid ultrasonography to determine endothelial function and carotid artery intima-media thickness, respectively. Results: No statistically significant differences in the allele or genotype frequencies for each individual MHCIITA gene polymorphism between RA patients who experienced CV events, or not, were found. This was also the case when each polymorphism was assessed according to results obtained from surrogate markers of atherosclerosis. Also, in assessing the combined influence of both MHCIITA gene polymorphisms in the risk of CV disease after adjustment for gender, age at time of disease diagnosis, follow-up time, traditional CV risk factors, and shared epitope status, patients with CV events only showed a marginally decreased frequency of the MHCIITA rs3087456-rs4774 G-G allele combination (p=0.08; odds ratio: 0.63 [95% confidence interval: 0.37-1.05]). Conclusions: Our data do not support an influence of MHCIITA rs3087456 and rs4774 polymorphisms in the increased risk of CV events of patients with RA.
The relationship between dietary inflammatory index and metabolic syndrome in patients with rheumatoid arthritis

Teymour Sheikhi,Yahya Pasdar,Jalal Moludi,Mehdi Moradinazar,Hadi Abdollahzad

DOI: https://doi.org/10.1108/nfs-10-2021-0302

2021-12-17

Abstract:Purpose Inflammation plays a significant role in incidence of metabolic syndrome (MetS), whose risk can be reduced through modifying the diet. Considering the importance of incidence of MetS among patients with rheumatoid arthritis (RA), this study aims to determine the relationship between dietary inflammatory index (DII) and MetS in these patients. Design/methodology/approach This study was performed on 261 adults 35–65 years of age suffering from RA. The patients were among the participants in Ravansar non-communicable disease prospective study. DII was calculated based on food frequency questionnaire. The components of MetS were measured according to the protocol of prospective epidemiological research studies in Iran cohort. Data analysis was carried out using univariate and multivariate logistic regression model by modifying the confounding variables. Findings In patients with RA, prevalence of MetS was 37.5%. The mean of DII in RA patients with MetS and without MetS was −2.3 ± 1.5 and −2.2 ± 1.6, respectively, with no significant difference between two groups. After modifying the variables of age and gender, the odds of increasing waist circumference (WC) were near 1.9 times greater in the fourth quartile (pro-inflammatory diet) compared to the first quartile of DII (anti-inflammatory diet) ( P = 0.03). The odds of developing hypertension was approximately 1.3 times greater in the fourth compared to the first quartile of DII ( P = 0.034). The odds of developing MetS increased by 27% in the fourth quartile in comparison to the first one, though this increase was not statistically significant. Originality/value In RA patients, with increase in DII score, the WC and blood pressure had increased. The DII had no significant relationship with MetS. Further studies are essential across larger populations to confirm the findings.
[Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid].

H. Mörk,O. Al-Taie,O. Klinge,M. Scheurlen

1997-12-01

Abstract:Drug-induced cholestasis can rarely persist for a considerable time period even after withdrawal of the drug. We report the case of a 55-year-old man with progressive jaundice after oral therapy with 17-alpha-methyltestosterone. Under empiric therapy with ursodeoxycholic acid the condition resolved completely. According to this observation, we suggest a therapeutic trial with ursodeoxycholic acid in cases of prolonged androgen-induced cholestasis.
MTHFR Gene Polymorphisms in Iraqi Kurdish Rheumatoid Arthritis Patients: Relation to Methotrexate Response and Toxicity

Sherzad Saeed Younis,Najlaa Kadhm Issa,Dhia Mustafa Sulaiman

DOI: https://doi.org/10.24996/ijs.2022.63.12.9

2022-12-30

Iraqi Journal of Science

Abstract:Methotrexate (MTX) is still one of the gold standard treatments for rheumatoid arthritis (RA). It shows diverse outcomes in blood level and clinical response, this was demonstrated by its relation to the genetic polymorphism in the pharmacogenetic study. This study aimed to investigate the role of methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms in relation to MTX efficacy and toxicity in Iraqi Kurdish RA patients. Sixty-four RA patients were involved in this study with an average age of 47.78 ±14.08 and female to male ratio of (8.1). Diagnosis and disease activity were confirmed. Blood analyses, including those of laboratory markers of disease activity, were done. The 28 joint disease activity score (DAS28-CRP) was calculated. MTHFR gene polymorphisms were analyzed by real-time polymerase chain reaction. The most frequent genotypes which were identified in RA patients were the CT genotype of the C677T single nucleotide polymorphism (SNP) (51.6%) and the AC genotype of the A1298C SNP (48.4%). Patients with non-response to treatment had high frequencies of genotypes CT and TT (58.0% and 12.0%) of the C677T SNP respectively, as compared to those in the responder group; 28.6% and 0.0%); T-allele was associated with drug non-responding OR=4.17, P value=.0.009, meanwhile; genotypes AC and CC of the A1298C SNP were seen in (54.0% and 16.0%) in non-responder group. Patients with active RA had increased frequencies of CT and TT genotypes of the C677T SNP (60.0% and16.0%) respectively as compared to those who were in remission (26.6% and 0.0%); T-allele was associated with high disease activity; OR = 5.11. No association was found between C677T SNP and A1298C SNP, and MTX level status (P> 0.05). However, the variant alleles (T and C) were associated with the MTX toxic level (OR: 2.05, 95% CI [0.97 – 4.32]) and (OR: 1.99, 95% CI [0.96 – 4.18]) respectively. This study suggests that genetic polymorphisms of MTHFR SNP (C677T and A1298C) are associated with MTX efficacy but not toxicity in RA patients. This may assist the physicians in personalizing RA treatment in Iraqi patients.
Dietary Intake and Risk of Rheumatoid Arthritis—a Cross Section Multicenter Study

Jing He,Yu Wang,Min Feng,Xia Zhang,Yue-Bo Jin,Xue Li,Lin-Chong Su,Shuang Liu,Ai-Xue Wang,Xiao-Mei Chen,Li-Jun Wu,Xiao-Xia Yu,Ning Xu,Xiang-Yuan Liu,Hui-Ming Yan,Yong-Fu Wang,Bin Jia,Jun-Fang Li,Jie-Mei Tao,Feng-Xiao Zhang,Ping Yu,Liu-Fu Cui,Jing Yang,Zhen-Bin Li,Jian-Li Xie,Ping Wei,Wen-Wen Sun,Lu Gong,Yong-Jing Cheng,Ci-Bo Huang,Xiao-Yuan Wang,Yi Wang,Hui-Fang Guo,Hong-Tao Jin,Xia Liu,Guo-Chun Wang,Yan-Hua Wang,Lan He,Yi Zhao,Xiao-Xia Li,Yan Zhang,Jian-Ping Guo,Zhan-Guo Li

DOI: https://doi.org/10.1007/s10067-016-3383-x

2016-01-01

Clinical Rheumatology

Abstract:Environmental factors play an important role in the development of rheumatoid arthritis (RA). Among these factors, smoking is generally considered to be an established risk factor for RA. Data regarding the impact of diet on risk of RA development is limited. This study assessed the impact of dietary patterns on RA susceptibility in Chinese populations. This was a large scale, case-control study composed of 968 patients with RA and 1037 matched healthy controls. Subjects were recruited from 18 teaching hospitals. Socio-demographic characteristics and dietary intakes 5 years prior to the onset of RA were reported by a self-administered questionnaire. Differences in quantity of consumption between cases and controls were analyzed by Student’s t test. Multiple logistic regression analysis was applied to identify independent dietary risk factor(s) responsible for RA susceptibility. Compared to healthy individuals, RA patients had decreased consumption of mushrooms ( P = 0.000), beans ( P = 0.006), citrus ( P = 0.000), poultry ( P = 0.000), fish ( P = 0.000), edible viscera ( P = 0.018), and dairy products ( P = 0.005). Multivariate analyses revealed that several dietary items may have protective effects on RA development, such as mushrooms (aOR = 0.669; 95%CI = 0.518–0.864, P = 0.002), citrus fruits (aOR = 0.990; 95%CI = 0.981–0.999, P = 0.04), and dairy products (aOR = 0.921; 95%CI 0.867–0.977, P = 0.006). Several dietary factors had independent effects on RA susceptibility. Dietary interventions may reduce the risk of RA.
Alcohol drinking and rheumatoid arthritis risk: A systematic review and dose-response meta- analysis of prospective cohort studies

Y. Dong,J. Webster,C. Uzokwe,D. Greenwood,L. Hardie,J. Cade

DOI: https://doi.org/10.1017/s0029665123004639

2024-01-09

Proceedings of The Nutrition Society

Abstract://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0029665123004639/resource/name/firstPage-pdf-S0029665123004639a.jpg

nutrition & dietetics
Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells

Elizabeth C. Rosser,Christopher J.M. Piper,Diana E. Matei,Paul A. Blair,André F. Rendeiro,Michael Orford,Dagmar G. Alber,Thomas Krausgruber,Diego Catalan,Nigel Klein,Jessica J. Manson,Ignat Drozdov,Christoph Bock,Lucy R. Wedderburn,Simon Eaton,Claudia Mauri

DOI: https://doi.org/10.1016/j.cmet.2020.03.003

IF: 29

2020-04-01

Cell Metabolism

Abstract:The differentiation of IL-10-producing regulatory B cells (Bregs) in response to gut-microbiota-derived signals supports the maintenance of tolerance. However, whether microbiota-derived metabolites can modulate Breg suppressive function remains unknown. Here, we demonstrate that rheumatoid arthritis (RA) patients and arthritic mice have a reduction in microbial-derived short-chain fatty acids (SCFAs) compared to healthy controls and that in mice, supplementation with the SCFA butyrate reduces arthritis severity. Butyrate supplementation suppresses arthritis in a Breg-dependent manner by increasing the level of the serotonin-derived metabolite 5-Hydroxyindole-3-acetic acid (5-HIAA), which activates the aryl-hydrocarbon receptor (AhR), a newly discovered transcriptional marker for Breg function. Thus, butyrate supplementation via AhR activation controls a molecular program that supports Breg function while inhibiting germinal center (GC) B cell and plasmablast differentiation. Our study demonstrates that butyrate supplementation may serve as a viable therapy for the amelioration of systemic autoimmune disorders.

cell biology,endocrinology & metabolism
The Contribution of Genetic Variation and Aberrant Methylation of Aryl Hydrocarbon Receptor Signaling Pathway Genes to Rheumatoid Arthritis

Tian-Ping Zhang,Rui Li,Hong-Miao Li,Nan Xiang,Zhen Tan,Guo-Sheng Wang,Xiao-Mei Li

DOI: https://doi.org/10.3389/fimmu.2022.823863

IF: 7.3

2022-03-02

Frontiers in Immunology

Abstract:The aryl hydrocarbon receptor (AHR) signaling pathway participates in immune regulation of multiple autoimmune diseases, including rheumatoid arthritis (RA). We conducted this study to investigate the association of AHR signaling pathway genes ( AHR , ARNT , AHRR ) single nucleotide polymorphisms (SNPs), as well as their methylation levels, with RA susceptibility. Nine SNPs ( AHR gene rs2066853, rs2158041, rs2282885, ARNT gene rs10847, rs1889740, rs11204735, AHRR gene rs2292596, rs2672725, rs349583) were genotyped via improved multiple ligase detection reaction (iMLDR) in 479 RA patients and 496 healthy controls. We used the Illumina Hiseq platform to detect methylation levels of these genes in 122 RA patients and 123 healthy controls. A significant increase in rs11204735 C allele frequency was observed in RA patients when compared to controls. Further, rs11204735 polymorphism was associated with a decreased risk of RA under the dominant model. ARNT CCC haplotype frequency was significantly increased in RA patients in comparison to controls. In the AHRR gene, rs2672725 GG genotype, G allele frequencies were significantly related to an increased risk of RA and rs2292596, rs2672725 polymorphism were significantly associated with an increased risk of RA under the dominant model, recessive model, respectively. However, no significant association was identified between AHR gene polymorphism and RA susceptibility. The AHR methylation level in RA patients was significantly higher than the controls, while AHRR methylation level was abnormally reduced in RA patients. In addition, AHRR rs2672725 genotype distribution was significantly associated with the AHRR methylation level among RA patients. In summary, ARNT rs11204735, AHRR rs2292596, and rs2672725 polymorphisms were associated with RA susceptibility and altered AHR , AHRR methylation levels were related to the risk of RA.

immunology
DNA Methylation of the MHC Region in Rheumatoid Arthritis: Perspectives and Challenges

Wenqing Qiu,Yun Liu

DOI: https://doi.org/10.3899/jrheum.191404

2020-01-01

Abstract:The MHC, which covers a region about 4 Mb at 6p21.3, is one of the most polymorphic regions in the human genome. With a high density of more than 200 genes, most of which are directly involved in the immune response to self or non-self antigens, MHC genes have long been associated with a wide range of complex human diseases, including autoimmune or inflammatory diseases and cancer. Rheumatoid arthritis (RA) is a systemic autoimmune disease; recent investigations in large genome-wide association studies using single-nucleotide polymorphisms have confirmed the correlation of classic HLA genes and non-classic HLA genes with RA in many populations1,2. Functional and structural analyses indicate that these genetic variants reside in the peptide-binding groove, which may affect the binding affinity of the citrullinated peptides, and eventually lead to the development of RA1,3. However, because of the heterogeneity among ethnic groups and clinical subtypes, the major RA-risk allele in MHC is quite different among different populations. For example, HLA-DRB1*04 includes the *04:01 and *04:04 alleles, which are the dominant RA-risk alleles in whites4, whereas DRB1*04:05/*0901 are the major RA-risk alleles in Asians, specifically for RA patients positive for anticitrullinated protein antibodies (ACPA)5,6. A recent … \n\nAddress correspondence to W. Qiu or Y. Liu, 130 Dong An Road, Shanghai, China. Email: qiuwq{at}fudan.edu.cn; yliu39{at}fudan.edu.cn.
Inhibition of differentiation and affinity purification with a monoclonal antibody to a myeloid cell differentiation-inducing protein.

Y. Shabo,L. Sachs

DOI: https://doi.org/10.1182/BLOOD.V72.5.1543.1543

IF: 20.3

1988-11-01

Blood

Abstract:The normal myeloid hematopoietic regulatory proteins include four growth-inducing proteins called colony-stimulating factors (CSF), including interleukin-3 (IL-3), or macrophage and granulocyte inducers, type 1 (MGI-1), and another type of protein (MGI-2) with no myeloid cell growth-inducing activity that induces differentiation of normal myeloid precursor cells and certain clones of myeloid leukemic cells. An IgG2a monoclonal antibody was prepared and it neutralized two forms of MGI-2 (MGI-2A and MGI-2B) produced by mouse Krebs ascites tumor cells. The monoclonal antibody was used for affinity purification of MGI-2. This antibody also neutralized MGI-2 produced by normal mouse macrophages, normal myeloblasts incubated with IL-3, and MGI-2 produced by the lungs and found in the serum of mice injected with lipopolysaccharide (LPS). The anti-MGI-2 antibody did not inhibit the activity of any one of the four myeloid growth-inducing proteins (CSF or IL-3 = MGI-1), IL-1, tumor necrosis factor, or lymphotoxin. This antibody also inhibited induction of differentiation of myeloid leukemic cells by LPS, which is mediated by the endogenous production of MGI-2, but did not inhibit induction of differentiation in these leukemic cells by dexamethasone or cytosine arabinoside, which is not mediated by MGI-2. Anti-MGI-2 antibody thus inhibited differentiation when MGI-2 was added externally to cells or when it was mediated by endogenously produced MGI-2.
Genetic Polymorphisms of GGH and ABCC2 Are Associated with Methotrexate Intolerance in Patients with Rheumatoid Arthritis

Alejandro Escudero-Contreras,Clementina López-Medina,Eduardo Collantes-Estévez,Rafaela Ortega-Castro,Jerusalem Calvo-Gutiérrez,Natalia Mena-Vázquez,Blanca Panero-Lamothe,Bárbara Manzanares-Martín,Rafael Cáliz-Cáliz,Alberto Jiménez-Morales,Mayte Ruiz-Jiménez,Pilar Font-Ugalde

DOI: https://doi.org/10.3390/jcm10184070

2021-09-09

Abstract:Objective: to identify new single-nucleotide polymorphisms (SNPs) in genes encoding proteins involved in methotrexate (MTX) metabolism and to evaluate the associations of these SNPs with MTX toxicity or intolerance in a southern Spanish cohort of patients with rheumatoid arthritis (RA). Methods: An observational, retrospective, and multicenter study was conducted at three participating hospitals in southern Spain. The main variable was intolerance to MTX (i.e., bDMARD monotherapy), defined as an interruption of treatment due to adverse events or toxicity. Patients being treated with MTX and bDMARDs (combined treatment) at the time of the study visit were considered "tolerant" of MTX. Ten polymorphisms were selected for sequencing in our patients according to a literature review. Each polymorphism was classified according to three possible genotypes (e.g., two homozygous (AA or GG) and one heterozygous (AG)), and the association of these combinations with MTX intolerance was evaluated. Results: A total of 227 patients were included in the final analysis (107 intolerant of MTX and 120 tolerant). A significant association was observed between MTX intolerance and the GGH-T401C AA/AG genotype (OR 2.13, 95% CI 1.06-4.29) in comparison with the GG genotype. On the other hand, an inverse association was observed between the ABCC2-C24T TT/TC genotype and intolerance to MTX (OR 0.59, 95% CI 0.35-1.00) in comparison with the CC genotype. Conclusion: This study provides new data on the association between genetic polymorphisms and MTX intolerance, which may contribute to the development of new biomarkers and personalized medicine in patients with RA.
184 EFFECT OF HISTONE DEACETYLASE INHIBITOR ON DEVELOPMENT OF EMBRYOS DERIVED FROM HEAT-SHOCKED BOVINE OOCYTES.

V. R. A. Mendes,R. Dias,J. F. Souza,E. D. Souza,C. Quintão,R. Batista,E. Costa,L. Camargo

DOI: https://doi.org/10.1071/RDv29n1Ab184

2017-01-25

Abstract:Heat shock affects the oocyte developmental competence and embryonic gene expression. We found that the chromatin organisation of embryos derived from heat-shocked oocytes can also be affected (Camargo et al. 2015 Reprod. Fert. Dev. 27, 132). This study aimed to evaluate whether Scriptaid, a histone deacetylase inhibitor able to modulate the chromatin structure, could influence the development of embryos derived from heat-shocked oocytes. Bovine oocytes were in vitro-matured under conventional temperature (38.5°C) for 24h (non-heat-shock; NHS group) or under 41.5°C for 12h followed by 38.5°C for 12h (heat-shock; HS group). In vitro fertilization was performed under 38.5°C with 5% CO2 in air for 20h. Right after the end of fertilization the presumptive zygotes from the NHS or HS groups were denuded and randomly exposed to 500 nM Scriptaid for 0, 12, or 24h, comprising 6 treatments as followa: NHS-0h (NHS without Scriptaid, n=185); NHS-12h (NHS plus Scriptaid for 12h, n=178); NHS-24h (NHS plus Scriptaid for 24h, n=177); HS-0h (HS without Scriptaid, n=187); HS-12h (HS plus Scriptaid for 12h, n=180); and HS-24h (HS plus Scriptaid for 24h, n=183). After Scriptaid exposure, zygotes were cultured in CR2aa plus 2.5% FCS at 38.5°C with 5% CO2, 5% O2, and 90% N2. Cleavage rate was calculated on Day 2 (44h post-fertilization) and blastocyst rates on Day 7 and 8 post-fertilization. Six replicates were carried out and data was analysed by logistic regression (Proc Logistic, SAS 9.2, SAS Institute Inc., Cary, NC). Significant data were interpreted as odd ratios considering the 95% confidence interval. Values are shown as mean±standard error of the mean. There was no difference (P>0.05) among NHS treatments (NHS-0h, NHS-12h, and NHS-24h) as well as among HS treatments (HS-0h, HS-12h, and HS-24h) for cleavage and blastocyst rates at Day 7. At Day 8, however, the blastocyst rate in the NHS group decreased (P<0.05) as the time of zygote exposure to Scriptaid increased to 24h (33.9±2.8 and 24.2±1.6% for NHS-0h and NHS-24h, respectively), whereas no difference (P>0.05) was found in the HS group (20.7±1.5, 21.2±1.6, and 20.5±2.4% for HS-0h, HS-12h, and HS-24h, respectively). Comparison between NHS and HS treatments showed that cleavage and blastocyst rates at Day 7 and 8 of NHS-0h (88.7±2.8, 30.1±1.5, and 33.9±2.8%, respectively) were superior (P<0.05) to HS-0h (79.3±3.2, 16.9±1.0, and 20.7±1.5%, respectively). Differences (P<0.05) between NHS-12h and HS-12h on blastocyst rates at Day 7 (32.8±3.8 v. 20.6±1.7%, respectively) and at Day 8 (31.7±2.7 v. 21.2±1.6%, respectively) were also found. However, no difference (P>0.05) between NHS-24h and HS-24h was found. We showed that Scriptaid for 24h right after IVF has a negative impact on further development of zygotes derived from oocytes matured under conventional temperature (NHS group), in contrast to zygotes derived from oocytes matured under high temperature (HS group). We concluded that the effect of Scriptaid on embryo development is influenced by the temperature during oocyte maturation.
Is tea consumption associated with reduction of risk of rheumatoid arthritis? A Swedish case-control study

Helga Westerlind,Ida Palmqvist,Saedis Saevarsdottir,Lars Alfredsson,Lars Klareskog,Daniela Di Giuseppe

DOI: https://doi.org/10.1186/s13075-021-02583-y

2021-08-07

Abstract:Abstract Background Tea is a popular beverage around the world and has properties that can affect the immune system. The association between tea consumption and the risk of rheumatoid arthritis (RA), a chronic autoimmune disease primarily affecting the joints, is not well studied and results are conflicting. Methods We collected data on tea consumption for 2237 incident RA cases diagnosed 2005–2018 and 4661 controls matched on age, sex, and residential area. Tea consumption was classified into no (0 cups/day), irregular (< 1 cup/day), regular (1–2 cups/day), and high (≥ 2 cups/day) consumption, and irregular consumption was used as the reference category. Missing data on tea consumption was classified as no consumers, and sensitivity analyses were performed to test this assumption. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using conditional logistic regression, adjusting for smoking, coffee, alcohol, educational level, and body mass index. We also performed stratified analysis on sex, anti-citrullinated autoantibody (ACPA) status, and smoking habits. Results Among the cases, we found 57.3% to be ever consumers of tea with 19.7 having a high tea consumption. Corresponding figures for the controls were 58.4% ever drinkers with 22.1% high tea consumers. High tea consumption had an inverse association to the risk of RA compared to irregular consumption [OR = 0.78 (95% CI 0.66–0.92)], but the association lost statistical significance in the adjusted model [adjusted OR (adjOR) = 0.85 (95% CI 0.71–1.01)]. Among non-tea consumers, a protective effect was also observed compared to irregular consumers [adjOR = 0.82 (95% CI 0.70–0.88)], but this association did not withstand sensitivity analysis, possibly due to bias. In the ACPA-positive group and among current smokers, a protective effect of tea consumption was observed among the high tea consumers [adjOR = 0.76 (95% CI 0.62–0.94) and adjOR = 0.60 (95% CI 0.38–0.95), respectively]. Conclusions This study suggests a protective effect of high consumption of tea, among smokers and for ACPA-positive RA. Trial registration Not applicable

rheumatology
Association Between Ccr6 and Rheumatoid Arthritis: A Meta-Analysis

Peng Cheng,Ying Zhang,Hui Huang,Weikai Zhang,Qing Yang,Fengjing Guo,Anmin Chen

2015-01-01

Abstract:Objective: Chemokine (C-C motif) receptor 6 gene (CCR6) polymorphism has been reported to be associated with rheumatoid arthritis (RA) in different ethnic populations. Moreover, its inhibition by monoclonal antibody in mouse model has suppressed arthritis. However, few replication studies have reported conflicting results about this association. Therefore, to establish that CCR6 indeed is a risk factor associated with RA among different ethnic populations, a comprehensive meta-analysis study was conducted. Methods: PubMed and MEDLINE databases were searched using the term ‘CCR6’ for all articles published before May 2014. All the replication studies examining the association between CCR6 and RA were reviewed for meta-analysis. Data were summarized using randomeffects meta-analysis. The heterogeneity and publication bias among studies were examined by χ2 -based Q statistic test and Egger’s test, respectively. Results: A total of 24955 RA patients and 56129 controls from seven articles were included in the meta-analysis. While CCR6 was a risk factor in Asian (OR = 1.19, 95% CI: 1.14-1.24) and European (OR = 1.14, 95% CI: 1.08-1.21) populations, it was indicated as a protective factor in African Americans (OR = 0.79, 95% CI: 0.62-0.96). Conclusions: Our meta-analysis study concludes that there is a significant association between CCR6 and RA in all racial groups except African-American subgroup, which require a large sample size for concrete prediction.
Influence of RFC1 c.80A>G Polymorphism on Methotrexate-Mediated Toxicity and Therapeutic Efficacy in Rheumatoid Arthritis: A Meta-analysis

Mohammad Naushad,Salman A. Alrokayan,Fahad N. Almajhdi,Tajamul Hussain,Shaik Mohammad Naushad

DOI: https://doi.org/10.1177/10600280211002053

IF: 3.4628

2021-03-22

Annals of Pharmacotherapy

Abstract:Background: Methotrexate (MTX) is an antirheumatic drug, transported by reduced folate carrier-1 (RFC1). The most common RFC1 gene variant, c.80 A>G (rs1051266) is ambiguously linked to adverse effects of MTX therapy in some rheumatoid arthritis (RA) patients. Objective: The purpose of meta-analysis was to summarize all major published studies on c.80 A>G SNP to clarify this ambiguity in MTX therapy. Methods: A total of 18 studies representing 3592 RA patients comprising 699 men and 2893 women were included. Both fixed and random effect models were applied to study the data. Results: The RFC1 80A-allele showed null association with MTX-mediated toxicity in both fixed (odds ratio [OR] = 0.91; 95% CI = 0.80-1.03) and random effects (OR = 0.89; 95% CI: 0.71-1.11) models. Because heterogeneity was observed in this association ( P = 0.0006), data were segregated based on use of folate therapy. In 7 studies (n = 1191) where folate was used along with MTX, RFC1 AA patients showed reduced risk for MTX-mediated toxicity (OR = 0.67; 95% CI: 0.50-0.89; P = 0.0006). The RFC1 80A-allele was found to increase the efficacy of MTX therapy by 1.53-fold (95% CI: 1.24-1.88), whereas the 80AA-genotype increased the efficacy by 1.85-fold (95% CI: 1.41-2.42). No publication bias was observed in these associations. Conclusion and Relevance: RFC1 c.80 A>G is an important pharmacogenetic determinant of MTX therapy in RA. The RFC1 80A-allele robustly increased therapeutic efficacy and safety when folate was used along with MTX. Findings are relevant to decision-making in the clinical use of MTX as a treatment for RA patients harboring the RFC1 gene variant.

pharmacology & pharmacy

Intolerance to caffeine may increase susceptibility to rheumatoid arthritis: comment on the article by Mikuls et al.

The Role of Dietary Fiber in Rheumatoid Arthritis Patients: A Feasibility Study

Long-term Consumption of Caffeine-Free High Sucrose Cola Beverages Aggravates the Pathogenesis of EAE in Mice

Influence of C677T Polymorphism of 5,10-Methylenetetrahydrofolate Reductase on Methotrexate Toxicity

Adenosine receptor A2a blockade by caffeine increases IFN–gamma production in Th1 cells from patients with rheumatoid arthritis

Effect of caffeine intake on self-reported and genetic prediction of osteoarthritis: an epidemiological study and Mendelian randomization analysis

Influence of MHCIITA rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis

The relationship between dietary inflammatory index and metabolic syndrome in patients with rheumatoid arthritis

[Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid].

MTHFR Gene Polymorphisms in Iraqi Kurdish Rheumatoid Arthritis Patients: Relation to Methotrexate Response and Toxicity

Dietary Intake and Risk of Rheumatoid Arthritis—a Cross Section Multicenter Study

Alcohol drinking and rheumatoid arthritis risk: A systematic review and dose-response meta- analysis of prospective cohort studies

Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells

The Contribution of Genetic Variation and Aberrant Methylation of Aryl Hydrocarbon Receptor Signaling Pathway Genes to Rheumatoid Arthritis

DNA Methylation of the MHC Region in Rheumatoid Arthritis: Perspectives and Challenges

Inhibition of differentiation and affinity purification with a monoclonal antibody to a myeloid cell differentiation-inducing protein.

Genetic Polymorphisms of GGH and ABCC2 Are Associated with Methotrexate Intolerance in Patients with Rheumatoid Arthritis

184 EFFECT OF HISTONE DEACETYLASE INHIBITOR ON DEVELOPMENT OF EMBRYOS DERIVED FROM HEAT-SHOCKED BOVINE OOCYTES.

Is tea consumption associated with reduction of risk of rheumatoid arthritis? A Swedish case-control study

Association Between Ccr6 and Rheumatoid Arthritis: A Meta-Analysis

Influence of RFC1 c.80A>G Polymorphism on Methotrexate-Mediated Toxicity and Therapeutic Efficacy in Rheumatoid Arthritis: A Meta-analysis